Literature DB >> 9805646

Prevalence of urinary tract symptoms in long-standing type 1 diabetes mellitus.

C M Ingberg1, M Palmer, E Schvarcz, J Aman.   

Abstract

The purpose of this study was to evaluate the prevalence of urinary tract symptoms in a population-based cohort of 109 young adult patients with Type 1 diabetes mellitus with onset at < 16 years versus 208 sex- and age-matched controls. A validated postal questionnaire was used (response rate 87.2% in diabetic patients vs 77.4% in controls). Diabetic female patients had been treated more often than controls with antibiotics for urinary tract infections (UTI): 35/48 and 39/82 respectively; p < 0.01. Diabetic female patients with HbA1c > 9.0% did not have significantly more treated UTIs than those with HbA1c < or = 9.0%. Diabetic female patients had more social problems than controls in daily life because of urinary tract problems (11/48 and 3/82 respectively; p < 0.005) and used clamps to prevent wetting more often than did controls (5/48 vs 1/82, p < 0.05), whereas diabetic male patients never used condoms to prevent wetting. In conclusion, female but not male diabetic patients with long-standing Type 1 diabetes mellitus had increased frequency of treated UTIs. Urinary tract problems also interfered with normal social activities in female diabetic patients who had a greater need for clamps to prevent wetting.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9805646

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  4 in total

1.  Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study.

Authors:  Aruna V Sarma; Alka Kanaya; Leroy M Nyberg; John W Kusek; Eric Vittinghoff; Brandy Rutledge; Patricia A Cleary; Patricia Gatcomb; Jeanette S Brown
Journal:  Urology       Date:  2009-04-10       Impact factor: 2.649

2.  Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection.

Authors:  Bryndís Ragnarsdóttir; Klas Jönsson; Alexander Urbano; Jenny Grönberg-Hernandez; Nataliya Lutay; Martti Tammi; Mattias Gustafsson; Ann-Charlotte Lundstedt; Irene Leijonhufvud; Diana Karpman; Björn Wullt; Lennart Truedsson; Ulf Jodal; Björn Andersson; Catharina Svanborg
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

Review 3.  Stem cells in clinical practice: applications and warnings.

Authors:  Daniele Lodi; Tommaso Iannitti; Beniamino Palmieri
Journal:  J Exp Clin Cancer Res       Date:  2011-01-17

Review 4.  Stem Cell Applications for Treatment of Cancer and Autoimmune Diseases: Its Promises, Obstacles, and Future Perspectives.

Authors:  Yousef M Hawsawi; Faisal Al-Zahrani; Charalampos Harris Mavromatis; Mohammed A Baghdadi; Shalini Saggu; Atif Abdulwahab A Oyouni
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.